Girls’s healthcare has traditionally been constructed on incomplete knowledge: U.S. scientific trials didn’t require feminine contributors till 1993, and that hole compounded throughout many years into misdiagnosis charges that exceed 50% for widespread vaginal circumstances and recurrence charges above 60% even after remedy. Vaginal signs are among the many main causes ladies search medical care within the U.S., but the microbiome driving most of these signs has barely been studied at scale, leaving clinicians to deal with complicated infections with blunt devices. Evvy addresses that hole straight, providing the world’s solely CLIA-certified, NYS CLEP-approved metagenomic sequencing take a look at that identifies 700+ micro organism and fungi from a single at-home swab, combining that with clinician-reviewed diagnoses, personalised remedy protocols, and longitudinal biomarker monitoring. The platform now serves greater than 100,000 sufferers and three,000 practitioners, has generated the world’s largest proprietary vaginal microbiome dataset, and is backed by 15+ peer-reviewed publications together with a research of 1,000+ real-world sufferers displaying a 50%+ discount in bacterial vaginosis recurrence versus normal of care. With its EvvyAI engine decoding that dataset in actual time, the corporate is now shifting from vaginal well being into fertility, the place a landmark potential research operating in IVF clinics is wrapping up.
AlleyWatch sat down with Evvy Cofounder and CEO Priyanka Jain to study extra concerning the enterprise, its future plans, current funding spherical, and far, way more…
Who had been your buyers and the way a lot did you increase?
We raised a $40M Sequence B, led by Catalio Capital Administration, with participation from new buyers together with Rethink Influence, Muse Capital, Flywheel Ventures, and Alumni Ventures, alongside present buyers together with Labcorp Enterprise Fund, Basic Catalyst, Left Lane Capital, BBG Ventures, Amboy Avenue Ventures, Ingeborg, and Foreground Capital. This brings our complete fairness raised to $60M.
Inform us concerning the services or products that Evvy provides.
Evvy is constructing the proof, infrastructure, and expertise to make precision, data-driven care the usual for girls’s well being. Evvy’s Vaginal Well being Check is the world’s solely CLIA-certified, NYS CLEP-approved metagenomic sequencing (mNGS) take a look at that uncovers 700+ microbes from a single at-home swab. A affected person takes the swab at house; we course of the pattern with our proprietary sequencing assay; we analyze the molecular outcomes alongside her signs and well being historical past; and a licensed clinician critiques the outcomes, delivers a prognosis, and — the place related — prescribes personalised remedy, all in underneath 7 days. It’s testing plus precision remedy plus longitudinal biomarker monitoring, serving 100k+ sufferers throughout vaginal infections, fertility, menopause, and extra.
What impressed the beginning of Evvy?
Girls hear “unexplained” continually — unexplained infertility, unexplained recurrence, unexplained ache. It’s said like a prognosis, when it actually simply means medication wasn’t constructed to measure feminine biology. The vaginal microbiome is an ideal instance of that blind spot: a strong, ignored biomarker that impacts fertility, preterm start, gynecological cancers, and extra — but it had by no means been studied or measured at scale. It’s a mix of stigma and a real analysis hole (ladies weren’t required to be included in U.S. scientific trials till 1993), and that mixture — not sufficient knowledge, not sufficient analysis, too many taboos, however enormous affected person affect — is strictly why we constructed Evvy.
How is Evvy totally different?
There are different firms providing vaginal-health testing or wellness-oriented microbiome merchandise, however Evvy is the one one combining clinical-grade metagenomic sequencing, full regulatory licensure, scientific diagnoses, and personalised care throughout vaginal well being, fertility, and menopause. Particularly: (1) we use metagenomic sequencing quite than PCR or 16S, so we detect all micro organism and fungi in a pattern, not a restricted panel; (2) we’re the one clinical-grade metagenomics take a look at licensed in all 50 states, with each take a look at ordered and reviewed by a licensed clinician (98% sensitivity / 99% specificity on CLEP validation); (3) we’re backed by 15+ peer-reviewed publications, together with validation of our personal take a look at methodology and a research of 1,000+ real-world BV sufferers displaying our strategy considerably improves outcomes; and (4) we’ve constructed the world’s largest vaginal microbiome dataset, which lets us really interpret a consequence for a person affected person quite than simply report it. (5) Lastly is our scale — Evvy is the world’s largest vaginal microbiome platform, serving over 100k+ sufferers and 3k+ clinicians.
What market does Evvy goal and the way huge is it?
Vaginal signs are one of many main causes ladies search healthcare within the U.S., but sufferers face 50%+ misdiagnosis charges and 60%+ recurrence charges in conventional care. We’re focusing on the ladies’s well being circumstances tied to the vaginal microbiome — vaginal infections right this moment, with fertility as our subsequent frontier, and finally irritation, PCOS, endometriosis, perimenopause, and HPV development. Collectively, these circumstances price the healthcare system greater than $180 billion in underserved outcomes.
What’s your small business mannequin?
Evvy is a testing-and-care platform: sufferers can entry the Vaginal Microbiome Check from our web site, and each take a look at contains clinician assessment and prognosis. The place clinically applicable, clinicians may prescribe remedy, which sufferers may fill by Evvy. Past customers, we’re increasing distribution by physicians, well being techniques, and digital-health and diagnostic companions.
How are you making ready for a possible financial slowdown?
We’ve constructed Evvy round an actual scientific want, not a discretionary wellness buy — sufferers come to us as a result of standard-of-care testing failed to elucidate their signs, and that demand doesn’t go away in a downturn. Our capital effectivity has at all times been a precedence: we’ve constructed the world’s largest proprietary vaginal microbiome dataset over 5 years on a comparatively lean increase, and this spherical offers us runway to maintain validating new diagnostic fashions without having to boost opportunistically.
What was the funding course of like?
It was thrilling, but it surely additionally jogged my memory that ladies’s well being remains to be within the comparatively early days for later-stage enterprise capital. On the seed and Sequence A phases, there’s been an enormous quantity of progress in buyers’ understanding that ladies’s well being is an enormous alternative. However as we moved into Sequence B, we had been speaking to a special group of growth-stage buyers, lots of whom haven’t seen many ladies’s well being firms attain this stage. There was nonetheless a number of schooling concerned – virtually like going again to our earliest fundraising days.
What are the most important challenges that you simply confronted whereas elevating capital?
The most important problem was serving to buyers perceive that the factor we’ve constructed doesn’t match neatly into an present class. We heard a model of the identical query from totally different sides of the funding ecosystem: Are you a shopper firm or a biotech firm? Some buyers noticed our shopper model and requested why we weren’t merely constructing a bigger shopper well being firm. Others noticed our dataset and AI infrastructure and requested why we had been spending time on the patron expertise.
Our reply is that we’re deliberately each. The buyer platform permits us to serve affected person wants right this moment whereas producing longitudinal real-world knowledge; the science and analysis engine permits us to show that knowledge into new diagnostic and care fashions. We predict the most important alternatives in healthcare exist on the intersection, and a lot of the fundraising course of was about telling that story clearly and discovering buyers who understood why the mixture issues.
What components about your small business led your buyers to put in writing the examine?
5 issues got here up repeatedly: (1) our novel take a look at and precision-medicine mannequin, versus simply one other telehealth providing; (2) our large-scale proprietary dataset; (3) confirmed market penetration and a trusted shopper model; (4) revealed, peer-reviewed proof on each take a look at accuracy and improved affected person outcomes; and (5) the scale of the chance — vaginal well being, fertility, and different indications the platform can broaden into. We’re particularly excited to have Catalio as our lead investor given their unimaginable experience in diagnostics and life sciences.
What are the milestones you propose to realize within the subsequent six months?
Our near-term focus is clinically validating a brand new era of EvvyAI-powered diagnostic and care fashions, beginning with fertility — we’re wrapping up a landmark potential research run in IVF clinics. Alongside that, we’re centered on increasing entry to Evvy’s platform by physicians, well being techniques, and digital-health companions.
What recommendation are you able to provide firms in New York that do not need a recent injection of capital within the financial institution?
Focus relentlessly on the factor that’s hardest to duplicate: a product prospects genuinely want, proof that it really works, and a enterprise mannequin that may develop into sturdy. New York is an unimaginable place to construct due to the density of expertise, prospects, scientific establishments, and capital—however these benefits matter most when you find yourself disciplined about priorities and sincere about what’s creating worth.
The place do you see the corporate going now over the close to time period?
We’re coming into what appears like a very thrilling new chapter for Evvy. For the primary 5 years, we centered on constructing the platform, serving sufferers, and creating the dataset. Now we’ve got greater than 100,000 sufferers and a physique of clinical-grade knowledge that lets us ask a lot greater questions. Close to time period, we’re beginning with fertility, whereas persevering with to construct out the vaginal well being platform that acquired us right here. We’ll validate new AI-powered diagnostic and care fashions, broaden by physicians and companions, and proceed discovering novel biomarkers throughout ladies’s well being.
Long term, the imaginative and prescient is a “new-age Pap smear” — an at-home, non-invasive pattern giving ladies common, data-rich perception throughout infections, irritation, fertility, PCOS, endometriosis, perimenopause, and HPV development. Finally, I need “unexplained” to develop into a a lot much less widespread phrase in ladies’s healthcare. We wish to construct the definitive diagnostic engine for girls’s well being – one which lastly makes the feminine physique measurable, comprehensible, and treatable with the identical degree of precision we count on in all places else in medication.
What’s your favourite fall vacation spot in and across the metropolis?
I like getting out of town within the fall – there’s one thing about seeing the leaves change that makes you decelerate just a little. The Hudson Valley is one in all my favourite locations to flee to for a weekend, particularly when you’ll be able to mix a hike with good meals and just a little time offline. However actually, probably the greatest issues about New York within the fall is that you simply don’t must go very far. A protracted stroll by Central Park on a crisp fall day is fairly exhausting to beat.
You’re seconds away from signing up for the most popular checklist in NYC Tech!
Join right this moment
